UPDATE : Wednesday, June 20, 2018
상단여백
YD Life Science preps diabetes complication therapy for global launch by Marian Chu 2018-04-10 17:36
JW Pharm discovers novel H4R antagonist for atopic dermatitis by Marian Chu 2018-04-10 17:36
Janssen Korea gets reimbursement for leukemia drug by Marian Chu 2018-04-10 16:14
LG Chem, Merck to co-market hypertension drug by So Jae-hyeon 2018-04-10 15:15
Il-yang’s ‘Supect’ loses 2nd indication for leukemia by Lee Hye-seon 2018-04-10 15:14
라인
Tamiflu crushed generic copies in flu season by So Jae-hyeon 2018-04-09 15:40
Biosimilars take on original at breast cancer conference by So Jae-hyeon 2018-04-09 15:05
Boehringer Ingelheim Korea CEO was forced to resign? by Nam Doo-hyun 2018-04-06 16:10
GC Pharma starts testing anti-EGFR monoclonal antibody by Lee Han-soo 2018-04-05 15:44
Janssen, Hanmi start phase-2 study on obesity, diabetes drug by So Jae-hyeon 2018-04-05 15:06
라인
Korean biosimilars rarely prescribed in US by So Jae-hyeon 2018-04-05 15:05
HanAll wins patent for monoclonal antibody in Taiwan by Lee Han-soo 2018-04-04 16:07
Will SGLT-2 combos with DPP-4 win insurance coverage? by So Jae-hyeon 2018-04-04 15:12
Outpatient drug prescriptions plunged in February by So Jae-hyeon 2018-04-03 16:59
Sanofi Genzyme Korea gets go-ahead to market Dupixent by Marian Chu 2018-04-03 15:23
라인
Ildong wins patent for retinal diseases biobetter treatment by Lee Han-soo 2018-04-03 14:35
Seoul orders Janssen to fill up PMS cases to 3,000 by Lee Hye-seon 2018-04-02 16:30
Boehringer Ingelheim’s COPD therapy may reduce exacerbation risk by Marian Chu 2018-04-02 15:14
Chinese lab ends Olita deal with Hanmi by So Jae-hyeon 2018-04-02 11:39
Daewoong, Yuhan in new rivalry to sell antidiabetic drugs by So Jae-hyeon 2018-03-30 16:23
여백
여백
여백
Back to Top